MEDICALPulmonaryHealth Calculator
🏥

Vital Capacity

Normal pulmonary function in healthy non-smoker

Did our AI summary help? Let us know.

Evidence-based calculations Used in clinical settings worldwide Regular monitoring recommended

Ready to run the numbers?

Why: This calculation helps assess important health parameters for clinical and personal wellness tracking.

How: Enter your values above and the calculator will apply validated formulas to compute your results.

Evidence-based calculationsUsed in clinical settings worldwide
Sources:Medical LiteratureWHO Guidelines

Run the calculator when you are ready.

Understanding Vital CapacityUse the calculator below to check your health metrics

Healthy Adult Male (35 years)

Normal pulmonary function in healthy non-smoker

Click to load

Restrictive Pattern (55 years)

Patient with interstitial lung disease showing reduced VC

Click to load

COPD Patient (65 years)

Long-term smoker with obstructive lung disease

Click to load

Healthy Female (40 years)

Normal lung function in adult female

Click to load

Neuromuscular Disease (50 years)

Patient with muscular weakness affecting respiratory muscles

Click to load

Sample Scenarios

Healthy Adult Male (35 years)

Normal pulmonary function in healthy non-smoker

Restrictive Pattern (55 years)

Patient with interstitial lung disease showing reduced VC

COPD Patient (65 years)

Long-term smoker with obstructive lung disease

Healthy Female (40 years)

Normal lung function in adult female

Neuromuscular Disease (50 years)

Patient with muscular weakness affecting respiratory muscles

Enter Patient Data

Demographics

Spirometry

Volumes

Clinical

For informational purposes only — not medical advice. Consult a healthcare professional before acting on results.

🏥 Health Facts

— WHO

— CDC

What is Vital Capacity?

Vital Capacity (VC) is the maximum amount of air a person can expel from the lungs after maximum inhalation. It equals the sum of tidal volume, inspiratory reserve volume, and expiratory reserve volume. VC is a key indicator of respiratory health and helps diagnose restrictive lung diseases.

Tidal Volume (TV)

Normal breathing volume (~500 mL at rest)

Inspiratory Reserve (IRV)

Extra air that can be inhaled (~2500 mL)

Expiratory Reserve (ERV)

Extra air that can be exhaled (~1000 mL)

Clinical Significance

  • Reduced VC suggests restrictive lung disease or neuromuscular weakness
  • Serial measurements track disease progression
  • Pre-operative assessment for surgical planning
  • Monitor respiratory muscle strength in neuromuscular disease

Understanding Vital Capacity

Vital Capacity (VC) is the maximum amount of air a person can expel from the lungs after maximum inhalation. It represents the sum of Inspiratory Reserve Volume (IRV), Tidal Volume (TV), and Expiratory Reserve Volume (ERV).

FVC

Forced Vital Capacity

Maximum exhaled with force

SVC

Slow Vital Capacity

Relaxed maximal exhale

IVC

Inspiratory VC

From RV to TLC

Lung Volume Components

Primary Volumes

  • • Tidal Volume (TV): ~500 mL - normal breath
  • • IRV: ~3,000 mL - extra after normal inhale
  • • ERV: ~1,100 mL - extra after normal exhale
  • • RV: ~1,200 mL - air remaining after max exhale

Lung Capacities

  • • VC: TV + IRV + ERV = ~4,600 mL
  • • TLC: VC + RV = ~5,800 mL
  • • IC: TV + IRV = ~3,500 mL
  • • FRC: ERV + RV = ~2,300 mL

Predicted Vital Capacity Equations

Males (NHANES III)

VC = (0.0576 × Height[cm]) - (0.026 × Age) - 4.34

Females (NHANES III)

VC = (0.0443 × Height[cm]) - (0.026 × Age) - 2.89

Note: Results are in Liters. Apply ethnicity corrections as needed:

  • • African American: multiply by 0.88
  • • Asian: multiply by 0.94

Clinical Interpretation

Normal

>80%

% predicted

Mild

70-79%

% predicted

Moderate

50-69%

% predicted

Severe

<50%

% predicted

Causes of Reduced Vital Capacity

Restrictive Disorders

  • • Interstitial lung disease (IPF, sarcoidosis)
  • • Pleural effusion
  • • Chest wall deformity (kyphoscoliosis)
  • • Neuromuscular disease (ALS, myasthenia)
  • • Obesity hypoventilation

Other Causes

  • • Post-surgical (thoracic, abdominal)
  • • Pain limiting deep inspiration
  • • Pregnancy (advanced)
  • • Ascites
  • • Poor effort during testing

Clinical Pearls

  • 💡FVC may be less than SVC in obstructive disease due to air trapping
  • 💡Serial VC measurements track neuromuscular disease progression
  • 💡VC <1L or <25% predicted suggests respiratory failure risk
  • 💡A >20% drop in supine vs sitting VC suggests diaphragm weakness
  • 💡TLC is needed to confirm restrictive disease (VC alone is not sufficient)
  • 💡Use LLN (lower limit of normal) instead of % predicted when available

Vital Capacity in Disease States

Neuromuscular Disease (ALS, MG)

  • • Monitor VC serially (monthly in ALS)
  • • VC <50% predicted - consider non-invasive ventilation
  • • VC <30% predicted - high risk of respiratory failure
  • • Check supine VC for diaphragm function

Interstitial Lung Disease

  • • Reduced VC with reduced TLC confirms restriction
  • • FVC decline >10% in 6 months is significant
  • • Combined with DLCO for prognosis
  • • FVC <50% associated with worse outcomes

Pre-operative Assessment

  • • VC <50% predicted increases surgical risk
  • • Used to predict post-operative pulmonary complications
  • • Consider optimization before elective surgery
  • • May influence anesthetic approach

Normal Vital Capacity Values

Adult Males

  • • Average: 4.6-4.8 L
  • • Range: 3.0-5.5 L
  • • Peak at age 20-25
  • • Declines ~25-30 mL/year after 30

Adult Females

  • • Average: 3.1-3.4 L
  • • Range: 2.0-4.0 L
  • • Peak at age 20-25
  • • Declines ~20-25 mL/year after 30

Factors Affecting Vital Capacity

Physiological

  • • Height (primary determinant)
  • • Age (decreases with age)
  • • Sex (males > females)
  • • Ethnicity
  • • Physical training

Posture Effects

  • • Standing > Sitting > Supine
  • • ~5-10% reduction supine
  • • Greater drop with diaphragm weakness
  • • Obesity affects supine more

Technical Factors

  • • Patient effort and cooperation
  • • Proper coaching
  • • Equipment calibration
  • • Recent bronchodilator use

Vital Capacity Quick Summary

Formula

VC = IRV + TV + ERV

Normal

>80% predicted

When to Measure Vital Capacity

Diagnostic Indications

  • • Unexplained dyspnea
  • • Suspected restrictive lung disease
  • • Neuromuscular disease evaluation
  • • Chest wall disorders
  • • Pre-operative assessment
  • • Disability evaluation

Monitoring Indications

  • • Progressive neuromuscular disease (ALS, MG)
  • • Interstitial lung disease progression
  • • Response to treatment (ILD, myositis)
  • • Post-transplant surveillance
  • • Occupational lung disease
  • • Chemotherapy-induced toxicity

VC Compared to Other Lung Volumes

  • • VC vs FVC: FVC is measured during forced expiration; VC is slow/relaxed. In obstruction, FVC may be less than VC due to dynamic airway collapse.
  • • VC vs TLC: TLC = VC + RV. TLC requires body plethysmography or gas dilution; VC can be measured with spirometry alone.
  • • VC vs IC: IC (Inspiratory Capacity) = TV + IRV. IC is measured from end-tidal expiration.
  • • VC and Restriction: Reduced VC suggests restriction but TLC is needed for confirmation. VC can also be reduced in severe obstruction with hyperinflation.

Quality Criteria for VC Measurement

Acceptability Criteria

  • • Full inspiration before starting exhale
  • • No leak during maneuver
  • • No cough during first second
  • • No early termination
  • • Smooth continuous flow

Repeatability Criteria

  • • Minimum 3 acceptable maneuvers
  • • Two largest VC within 150 mL
  • • Maximum 8 attempts
  • • Report best VC value

Special Populations

Elderly Patients

  • • VC naturally declines with age
  • • Use age-appropriate reference equations
  • • May have difficulty with prolonged maneuvers
  • • Consider LLN rather than fixed cutoffs

Pediatric Patients

  • • Use pediatric reference equations
  • • VC increases with growth
  • • May need incentive spirometry
  • • GLI-2012 equations available

Obese Patients

  • • ERV primarily affected (reduced)
  • • May appear mildly restrictive
  • • Supine VC further reduced
  • • Consider upright positioning

Athletes

  • • May have VC >100% predicted
  • • Endurance athletes: highest values
  • • Use caution with upper limit interpretation
  • • Consider athlete-specific references

VC Patterns in Disease

Restrictive Pattern

VC reduced, FEV1/FVC normal or increased, TLC reduced. Examples: IPF, sarcoidosis, kyphoscoliosis.

Obstructive Pattern

FVC may be reduced due to air trapping, but TLC is normal or increased. FEV1/FVC reduced. Examples: COPD, asthma.

Mixed Pattern

Both obstructive and restrictive features. FEV1/FVC reduced AND TLC reduced. Examples: COPD with ILD, cystic fibrosis.

Neuromuscular Weakness

VC reduced with preserved TLC (RV increased). Supine VC drops >20%. MIP/MEP also reduced. Examples: ALS, myasthenia gravis.

VC Monitoring Protocol

ALS/Neuromuscular

  • • Every 1-3 months
  • • Seated AND supine
  • • Include MIP/MEP
  • • Track decline rate

Interstitial Lung Disease

  • • Every 3-6 months
  • • Include DLCO
  • • Correlate with HRCT
  • • >10% decline is significant

Post-Treatment

  • • 4-8 weeks post-treatment
  • • Assess response
  • • Compare to baseline
  • • Consider variability

Related Measurements

  • FVC: Forced Vital Capacity (maximal forced expiration)
  • SVC: Slow Vital Capacity (relaxed expiration)
  • IVC: Inspiratory Vital Capacity (RV to TLC)
  • TLC: Total Lung Capacity = VC + RV
  • IC: Inspiratory Capacity = TV + IRV
  • FRC: Functional Residual Capacity = ERV + RV

Limitations of VC Measurement

  • • Effort-dependent: Requires patient cooperation and coaching
  • • Not specific for restriction: Can be reduced in obstruction (air trapping)
  • • Cannot measure RV: Need plethysmography or gas dilution for TLC
  • • Reference equation variability: Different equations give different predicted values
  • • Posture effects: Varies with body position
  • • Short-term variability: Day-to-day variation of ~5-10%

VC in Pre-operative Assessment

Thoracic Surgery

  • • VC >60% predicted: Generally acceptable
  • • VC 50-60%: Increased risk, optimize first
  • • VC <50%: High risk, consider alternatives
  • • Predicted post-op FEV1/DLCO key factors

Abdominal Surgery

  • • VC drops 40-60% after upper abdominal surgery
  • • Returns to baseline by 7-10 days
  • • Lower VC = higher risk of PPCs
  • • Incentive spirometry reduces complications

Diaphragm Weakness Assessment

Comparing seated and supine vital capacity is a simple method to assess diaphragm function.

Normal

<10%

Supine drop

Borderline

10-20%

Supine drop

Abnormal

>20%

Suggests diaphragm weakness

VC Thresholds for Respiratory Support

Non-invasive Ventilation (NIV)

  • • Consider NIV when VC <50% predicted
  • • Especially if symptoms present
  • • Or if orthopnea/supine drop >20%
  • • Start with nocturnal NIV

High Risk of Respiratory Failure

  • • VC <30% predicted
  • • VC <1 Liter
  • • Rapid decline (>100 mL/month in ALS)
  • • Discuss goals of care/tracheostomy

Reference Equations for Predicted VC

NHANES III (Caucasian)

Male: FVC = 0.0576 × H - 0.026 × A - 4.34

Female: FVC = 0.0443 × H - 0.026 × A - 2.89

GLI-2012 (Multi-ethnic)

Uses spline functions for age, height, and ethnicity. Recommended by ATS/ERS. Provides LLN and z-scores.

Ethnicity Corrections

  • • African American: × 0.88
  • • Asian: × 0.94
  • • Hispanic: Use NHANES III Hispanic equations

Expected VC Changes with Treatment

May Improve

  • • Myasthenia gravis (with treatment)
  • • Inflammatory myopathies
  • • Pleural effusion (after drainage)
  • • Obesity (after weight loss)
  • • Post-surgical recovery

Usually Progressive Decline

  • • ALS (2-4% per month)
  • • IPF (5-10% per year)
  • • Duchenne muscular dystrophy
  • • Progressive systemic sclerosis
  • • Kyphoscoliosis (with progression)

VC Interpretation Algorithm

  1. 1. Calculate % predicted VC (or use LLN)
  2. 2. If VC <80% predicted (or below LLN):
  3. a. Check FEV1/FVC ratio
  4. b. If FEV1/FVC normal/high → suspect restriction → confirm with TLC
  5. c. If FEV1/FVC low → obstruction with possible air trapping
  6. 3. If TLC reduced → true restriction
  7. 4. If TLC normal/elevated → pseudorestriction from air trapping
  8. 5. Check supine VC if neuromuscular disease suspected
  9. 6. Correlate with symptoms, imaging, and clinical context

Clinical Scenario Examples

Healthy 30-year-old male, 175 cm

Predicted VC ~5.0L, Measured VC 4.8L (96% predicted) - Normal

65-year-old female with IPF, 160 cm

Predicted VC ~2.8L, Measured VC 1.7L (61% predicted) - Moderate restriction

55-year-old male with ALS, 178 cm

Predicted VC ~4.5L, Measured sitting 1.8L (40%), Supine 1.2L (27%) - Severe with diaphragm weakness, consider NIV

Key Formulas Summary

  • VC: IRV + TV + ERV
  • TLC: VC + RV
  • IC: TV + IRV
  • FRC: ERV + RV
  • % Predicted: (Measured / Predicted) × 100
  • Supine drop: ((Sitting - Supine) / Sitting) × 100

Lung Volume Relationships

TLC

5,800 mL

Maximum capacity

VC

4,600 mL

Max in - max out

FRC

2,300 mL

End normal exhale

RV

1,200 mL

After max exhale

Values shown are approximate averages for healthy adult males

Differential Diagnosis of Reduced VC

Parenchymal

  • • Idiopathic pulmonary fibrosis
  • • Sarcoidosis
  • • Hypersensitivity pneumonitis
  • • Drug-induced ILD
  • • Radiation fibrosis
  • • Pneumoconiosis

Chest Wall/Pleural

  • • Kyphoscoliosis
  • • Ankylosing spondylitis
  • • Pleural effusion
  • • Pleural thickening
  • • Obesity
  • • Thoracoplasty

Neuromuscular

  • • ALS
  • • Myasthenia gravis
  • • Muscular dystrophy
  • • Guillain-Barré syndrome
  • • Diaphragm paralysis
  • • Spinal cord injury

Additional Testing Based on VC Results

If Restriction Suspected

  • • Full lung volumes (TLC by plethysmography)
  • • DLCO (diffusing capacity)
  • • HRCT chest
  • • Consider bronchoscopy/biopsy
  • • Autoimmune panel if CTD suspected

If Neuromuscular Suspected

  • • Supine vs sitting VC
  • • MIP (Maximal Inspiratory Pressure)
  • • MEP (Maximal Expiratory Pressure)
  • • Sniff nasal pressure
  • • EMG/nerve conduction studies

Treatment Implications Based on VC

VC >70% Predicted

  • • Monitor disease progression
  • • Pulmonary rehabilitation
  • • Smoking cessation if applicable
  • • Treat underlying condition

VC 50-70% Predicted

  • • Consider nocturnal NIV
  • • Cough assist devices
  • • Intensive pulmonary rehab
  • • Vaccinations important

VC 30-50% Predicted

  • • Start/optimize NIV
  • • Lung transplant evaluation
  • • Advance care planning
  • • Oxygen therapy if hypoxic

VC <30% Predicted

  • • High risk respiratory failure
  • • 24-hour ventilation may be needed
  • • Discuss tracheostomy if appropriate
  • • Goals of care discussions critical

Interpreting VC Trends Over Time

  • • Normal aging: ~25-30 mL/year decline in males, ~20-25 mL/year in females
  • • IPF: Decline >5-10% annually considered significant progression
  • • ALS: Decline of 2-4% per month (very rapid)
  • • Significant change: Generally >12% from baseline or >200 mL
  • • Day-to-day variability: Up to 5-10% is normal
  • • Week-to-week: Changes >10% likely significant
  • • Response to treatment: Improvement >10% suggests positive response

Quick Reference: Normal VC by Height

Males (Age 40)

  • • 160 cm: ~4.0 L
  • • 170 cm: ~4.6 L
  • • 180 cm: ~5.2 L
  • • 190 cm: ~5.8 L

Females (Age 40)

  • • 150 cm: ~2.5 L
  • • 160 cm: ~3.0 L
  • • 170 cm: ~3.5 L
  • • 180 cm: ~4.0 L

Related Respiratory Muscle Tests

MIP (Maximal Inspiratory Pressure)

  • • Normal: >80 cmH2O (males)
  • • Normal: >60 cmH2O (females)
  • • Measures inspiratory muscle strength
  • • <30% predicted = ventilatory failure risk

MEP (Maximal Expiratory Pressure)

  • • Normal: >100 cmH2O (males)
  • • Normal: >80 cmH2O (females)
  • • Measures expiratory muscle strength
  • • Important for cough effectiveness

SNIP (Sniff Nasal Pressure)

  • • Normal: >70 cmH2O (males)
  • • Normal: >60 cmH2O (females)
  • • Reflects diaphragm strength
  • • Easier than MIP for some patients

Common Errors in VC Measurement

Patient-Related Errors

  • • Submaximal inspiration
  • • Early termination of exhale
  • • Air leak around mouthpiece
  • • Cough during maneuver
  • • Poor posture

Solutions

  • • Clear coaching and demonstration
  • • Encourage maximal effort
  • • Proper nose clip use
  • • Multiple attempts (up to 8)
  • • Seated upright position

Physiology of Vital Capacity

  • • Inspiration: Diaphragm contracts and flattens, external intercostals elevate ribs, pleural pressure becomes more negative, air flows in
  • • Expiration (quiet): Passive elastic recoil of lungs and chest wall
  • • Forced expiration: Abdominal muscles and internal intercostals contract actively
  • • VC determinants: Lung elastic recoil, chest wall compliance, respiratory muscle strength
  • • Aging effects: Decreased elastic recoil, increased chest wall stiffness, reduced muscle strength
  • • Training effects: Athletes can increase VC through conditioning

VC Interpretation Summary

>80%

Normal

70-79%

Mild reduction

50-69%

Moderate reduction

<50%

Severe reduction

Practical Tips for VC Testing

Before Testing

  • • Explain procedure clearly to patient
  • • Demonstrate the maneuver
  • • Ensure comfortable seated position
  • • Apply nose clip securely
  • • Record height and weight accurately

During Testing

  • • Coach enthusiastically ("big breath in!")
  • • Watch for air leaks
  • • Ensure complete inspiration before exhale
  • • Encourage full exhalation
  • • Allow rest between attempts

Documentation Requirements

  • • Patient demographics: Age, sex, height, weight, ethnicity
  • • Test conditions: Position (seated/standing), time of day, bronchodilator use
  • • Quality indicators: Number of acceptable maneuvers, repeatability achieved
  • • Results: Best VC (L), predicted VC (L), % predicted, LLN, z-score if available
  • • Reference equation used: NHANES III, GLI-2012, etc.
  • • Interpretation: Normal, mild/moderate/severe reduction, pattern
  • • Comparison to prior: If available, note change from baseline

When to Repeat VC Testing

Routine Monitoring

  • • Chronic ILD: Every 3-6 months
  • • Stable neuromuscular: Every 3-6 months
  • • Progressive ALS: Every 1-3 months
  • • After treatment changes

Symptom-Triggered

  • • New or worsening dyspnea
  • • Increasing orthopnea
  • • Sleep-disordered breathing
  • • Declining exercise tolerance

Vital Capacity Quick Facts

  • • Definition: Maximum air exhaled after maximum inspiration (IRV + TV + ERV)
  • • Normal values: Males 4.6-4.8L, Females 3.1-3.4L (adults)
  • • Primary determinant: Height (taller = higher VC)
  • • Age effect: Peaks at 20-25, then declines 25-30 mL/year
  • • Restriction indicator: Reduced VC suggests restriction, but confirm with TLC
  • • Critical threshold: VC <1L or <30% = high respiratory failure risk

Need Personalized Lung Function Analysis?

Get AI-powered interpretation and recommendations.

👈 START HERE
⬅️Jump in and explore the concept!
AI

Related Calculators

FEV1/FVC Ratio Calculator

Calculate the FEV1/FVC ratio for spirometry interpretation. Differentiate between obstructive and restrictive lung disease patterns.

Health

Lung Capacity Calculator

Calculate lung volumes and capacities including TLC, FRC, RV, and vital capacity. Essential for pulmonary function test interpretation.

Health

Peak Flow Calculator

Calculate predicted Peak Expiratory Flow Rate (PEFR) and assess asthma control using traffic light zones. Essential for asthma action plans.

Health

A-a Gradient Calculator

Calculate the Alveolar-arterial (A-a) oxygen gradient to assess oxygenation efficiency. Helps differentiate between pulmonary and extrapulmonary causes of...

Health

BODE Index Calculator

Calculate the BODE Index for COPD prognosis. Combines BMI, Obstruction (FEV1), Dyspnea (mMRC), and Exercise capacity (6MWD) to predict mortality.

Health

CURB-65 Calculator

Calculate the CURB-65 score for community-acquired pneumonia severity. Assesses Confusion, Urea, Respiratory rate, Blood pressure, and age ≥65 to guide...

Health